ArticleHypertension (Dallas, Tex. : 1979)2018
Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein).
Open access · bronzeAbstract read
In one paragraph
Article in Hypertension (Dallas, Tex. : 1979), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Genome-Wide Meta-Analysis of Blood Pressure Response to βJournal of the American Heart Association · 2019Pooled it
- Chemistry and Biological Activity of 11Molecules (Basel, Switzerland) · 2026Review
- Comparative GWAS using global and Indian Reference Panels reveals non-coding drivers of COVID-19 severity and mortality.PLoS neglected tropical diseases · 2026Article
- Insights into platypus crural gland transcriptomics - venom and beyond.BMC genomics · 2025Article
- The state of the art in secondary pharmacology and its impact on the safety of new medicines.Nature reviews. Drug discovery · 2024Review
- B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis.Frontiers in pharmacology · 2024Article
- miR-4432 Targets FGFBP1 in Human Endothelial Cells.Biology · 2023Article
- Evaluation of the Effect of the Fibroblast Growth Factor Type 2 (FGF-2) Administration on Placental Gene Expression in a Murine Model of Preeclampsia Induced by L-NAME.International journal of molecular sciences · 2022Article
- New developments in the biology of fibroblast growth factors.WIREs mechanisms of disease · 2022Review
- Plasma human growth cytokines in children with vasovagal syncope.Frontiers in cardiovascular medicine · 2022Article
- Association of circulating fibroblast growth factor-2 with progression of HIV-chronic kidney diseases in children.Pediatric nephrology (Berlin, Germany) · 2021Article
- Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells.Frontiers in cell and developmental biology · 2021Article
- Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1).Hypertension (Dallas, Tex. : 1979) · 2020Article
- Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats.Hypertension research : official journal of the Japanese Society of Hypertension · 2020Article
- Plasma and Urinary FGF-2 and VEGF-A Levels Identify Children at Risk for Severe Bleeding after Pediatric Cardiopulmonary Bypass: A Pilot Study.Medical research archives · 2020Article
- Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism.Scientific reports · 2018Article
- FGF binding proteins (FGFBPs): Modulators of FGF signaling in the developing, adult, and stressed nervous system.Biochimica et biophysica acta. Molecular basis of disease · 2018Review
- lncRNA MIAT suppression alleviates corneal angiogenesis through regulating miR-1246/ACE.Cell cycle (Georgetown, Tex.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Elena TassiFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
En Yin LaiFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Lingli LiFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Glenn SolisFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Yifan ChenFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
William E KietzmanFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Patricio E RayFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Anna T RiegelFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
William J WelchFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Christopher S WilcoxFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.).
Anton WellsteinFrom the Lombardi Cancer Center (E.T., W.E.K., A.T.R., A.W.) and Division of Nephrology and Hypertension (E.Y.L., L.L., G.S., Y.C., W.J.W., C.S.W.), Georgetown University, Washington, DC; Department of Physiology, Zhejiang University, Hangzhou, China (E.Y.L.); and Children's National Medical Center, George Washington University, DC (P.E.R.). anton.wellstein@georgetown.edu.
Zhejiang University · CN
Funding
Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5MRenal Vascular Oxidative Stress in HypertensionP01HL068686 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A., SANDBERG, KATHRYN L · 2001 to 2017
$28.8MTRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8MRole of bFGF low affinity receptors in childhood HIVANR01DK049419 · NIDDK · UNIVERSITY OF VIRGINIA · PI PATRICIO E. RAY · 1994 to 2026
$7.4MREGULATION OF RENAL FUNCTION AND BP BY THROMBOXANER37DK036079 · NIDDK · GEORGETOWN UNIVERSITY · PI WILCOX, CHRISTOPHER S · 2003 to 2012
$5.2MNITRIC OXIDE SYNTHASE IN THE JUXTAGLOMERULAR APPARATUSR01DK049870 · NIDDK · GEORGETOWN UNIVERSITY · PI WILCOX, CHRISTOPHER S · 1994 to 2014
$4.6MRole of heparin binding growth factors in vascular leakage and fatal bleedingR01HL102497 · NHLBI · UNIVERSITY OF VIRGINIA · PI RAY, PATRICIO E. · 2009 to 2018
$3.4MBIOLOGY AND PATHOLOGY OF A MODULATOR OF FGFR01CA071508 · NCI · GEORGETOWN UNIVERSITY · PI WELLSTEIN, ANTON · 1997 to 2010
$2.9MPathogenesis of chronic renal injury and hypertension in HIV-infected childrenR01DK108368 · NIDDK · UNIVERSITY OF VIRGINIA · PI RAY, PATRICIO E. · 2015 to 2019
$1.5MRegulation of Renal Function and BP by ThromboxaneR01DK109272 · NIDDK · GEORGETOWN UNIVERSITY · PI WELCH, WILLIAM J, WILCOX, CHRISTOPHER S · 2016 to 2019
$1.4MREGULATION OF RENAL FUNCTION AND BP BY THROMBOXANER01DK036079 · NIDDK · UNIVERSITY OF FLORIDA · PI WILCOX, CHRISTOPHER S · 1986 to 2002
$830kNCI NIH HHS P30 CA051008NCI NIH HHS R01 CA071508NCI NIH HHS T32 CA009686NHLBI NIH HHS P01 HL068686NHLBI NIH HHS R01 HL102497NIDDK NIH HHS R01 DK036079NIDDK NIH HHS R01 DK049419NIDDK NIH HHS R01 DK049870NIDDK NIH HHS R01 DK108368NIDDK NIH HHS R01 DK109272NIDDK NIH HHS R37 DK036079
Abstract
Fibroblast growth factors (FGFs) participate in organ development and tissue maintenance, as well as the control of vascular function. The paracrine-acting FGFs are stored in the extracellular matrix, and their release is controlled by a secreted FGF-binding protein (FGF-BP, FGFBP1, and BP1) that modulates FGF receptor signaling. A genetic polymorphism in the human
Indexed as
Blood PressureHypertensionVasoconstrictionAngiotensin II Type 1 Receptor BlockersAnimalsBenzimidazolesBiphenyl CompoundsCarrier ProteinsCyclic N-OxidesDisease Models, AnimalFibroblast Growth FactorsHumansIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMiceMice, TransgenicAngiotensin II Type 1 Receptor BlockersBenzimidazolesBiphenyl CompoundscandesartanCarrier ProteinsCyclic N-OxidesFGFBP1 protein, humanFgfbp1 protein, mouseFibroblast Growth FactorsIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMitogen-Activated Protein KinasesProtein Synthesis InhibitorsSpin LabelstempolTetrazolesangiotensin IIblood pressurefibroblast growth factorreactive oxygen speciesvascular resistance
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.